With every passing day, new discoveries are made that lend support to the increasing and important role biomarker analysis and tumor profiling play in personalized cancer care. Caris Life Sciences® is actively participating in research to advance the understanding of molecular science, further enabling the delivery of precision medicine.

Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapy

Identification of molecular targets in vulvar cancers

Comparative molecular profiling of HPV-induced squamous cell carcinomas

BRCA2, EGFR, and NTRK mutations in mismatch repair-deficient colorectal cancers with MSH2 or MLH1 mutations

Mismatch-repair deficiency predicts response of solid tumors to PD-1 blockade

RNASeq analysis of glioma tumors reveal targetable gene fusions

Localization of non-receptor tyrosine kinase (nRTK) variants identified in solid tumor patients with Next-Generation Sequencing (NGS)

Prevalence of homologous recombination deficiency among all tumor types

Colorectal cancer: Impact of primary tumor location on genetic alterations

Spectrum of tumor mutational load (TML) in genitourinary (GU) cancers